awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35674216-9BED05FC-9013-49FA-81D3-4C9EFEF14E8B
Q35674216-9BED05FC-9013-49FA-81D3-4C9EFEF14E8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35674216-9BED05FC-9013-49FA-81D3-4C9EFEF14E8B
Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy.
P2860
Q35674216-9BED05FC-9013-49FA-81D3-4C9EFEF14E8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35674216-9BED05FC-9013-49FA-81D3-4C9EFEF14E8B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cbf302f6442ba1682f2629e586281fdbb5dafab8
P2860
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.